852 results on '"Kawaguchi, Tomoya"'
Search Results
102. Clopidogrel-induced Eosinophilia with Hypercalcemia
103. Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non–Small-Cell Lung Cancer?: A Pooled Analysis of the Literature
104. Continued treatment with gefitinib beyond progressive disease benefits patients with activating EGFR mutations
105. Prospective Assessment of Continuation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Pemetrexed
106. Optimizing LiMn1.5M0.5O4 cathode materials for aqueous photo-rechargeable batteries.
107. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations
108. Chemotherapy is Beneficial for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Patients Aged 70-74, 75-79, and 80 or Older in Japan
109. A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905
110. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer
111. Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer
112. Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma
113. Strain Evolution in Pt-Ni Alloy Nanoparticles during Electrochemical Ni Leaching Revealed By Bragg Coherent Diffraction Imaging
114. P28-11 The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion
115. Stern layers on RuO2 (100) and (110) in electrolyte: Surface X-ray scattering studies
116. Ethnic Difference in Hematological Toxicity in Patients with Non-small Cell Lung Cancer Treated with Chemotherapy: A Pooled Analysis on Asian versus Non-Asian in Phase II and III Clinical Trials
117. Duration of prior gefitinib treatment predicts survival potential in patients with lung adenocarcinoma receiving subsequent erlotinib
118. Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
119. Differential properties of KRAS transversion and transition mutations in non-small lung cancer: associations with environmental factors and clinical outcomes
120. Influences of Enhanced Entropy in Layered Rocksalt Oxide Cathodes for Lithium-Ion Batteries
121. Safe Concurrent Use of Anti-tuberculosis Drugs and Pembrolizumab in a Patient with Non-small-cell Lung Cancer Who Was Infected with Mycobacterium tuberculosis
122. Do Metal Concentrations at Water Quality Monitoring River Sites Downstream of Legacy Mines Meet Environmental Quality Standards If Untreated Mine Drainages Are Discharged?
123. Additional file 1 of Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
124. Additional file 1 of Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
125. Gender, Histology, and Time of Diagnosis Are Important Factors for Prognosis: Analysis of 1499 Never-Smokers with Advanced Non-small Cell Lung Cancer in Japan
126. Japanese Ethnicity Compared with Caucasian Ethnicity and Never-Smoking Status Are Independent Favorable Prognostic Factors for Overall Survival in Non-small Cell Lung Cancer: A Collaborative Epidemiologic Study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry Databases
127. Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLC
128. Evaluating the Validity of a Hydrogen Mapping Method Based on Laser-induced Breakdown Spectroscopy
129. Therapeutic Strategies in EGFR Mutant Lung Cancer
130. Response biomarkers of inhalation exposure to cigarette smoke in the mouse lung
131. Impact of the COVID-19 Pandemic on Patients with Gastrointestinal Cancer Undergoing Active Cancer Treatment in an Ambulatory Therapy Center: The Patients’ Perspective
132. Decreased Level of Phosphatase and Tensin Homolog Deleted from Chromosome 10 (PTEN), a Negative Regulator of Phosphoinositide 3-kinase (PI3K)/Serine-threonine Protein Kinase (Akt) Pathway, is Related to Chronic Obstructive Pulmonary Disease
133. Serum Myostatin Level in COPD Patients with and without Sarcopenia : Application for Biomarker of Sarcopenia Diagnosis
134. Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004
135. Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis
136. Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or Erlotinib
137. Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion
138. Isoniazid-induced Immune Thrombocytopenia
139. Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non–Small Cell Lung Cancer
140. Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia
141. Bronchial Artery Aneurysm: Prevalence, Clinical Characteristics, and Long-Term Prognosis Following Bronchial Artery Embolization
142. Safety Profile and Risk Factors for Bleeding in Transbronchial Cryobiopsy Using a Two-Scope Technique for Peripheral Pulmonary Lesions
143. The Fermented Soy Product ImmuBalanceTM Suppresses Airway Inflammation in a Murine Model of Asthma
144. Phase I/II Study of Docetaxel and S-1 in Patients with Previously Treated Non-small Cell Lung Cancer
145. EGFR Polymorphism of the Kinase Domain in Japanese Lung Cancer
146. A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib
147. Early Pharmacodynamic Assessment Using 18F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction
148. A Case of Pulmonary Mucoepidermoid Carcinoma Responding to Carboplatin and Paclitaxel
149. EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer
150. Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniaevia binding to the RNA polymerase β subunit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.